Latest Exploration News

Gold Road Resources reports a robust half-year profit surge driven by higher gold prices and sales, while advancing a proposed acquisition by Gold Fields with a shareholder vote set for September.

Sayona Mining delivered record lithium production and sales in FY25 but reported a $382 million loss due to asset impairments amid falling lithium prices. The company is poised for transformation with its imminent merger with Piedmont Lithium.

Sayona Mining delivered record lithium concentrate production and sales in FY25, driving revenue to $223 million despite a 16% drop in selling prices. The company also recorded a significant $271 million impairment on its North American Lithium assets amid weaker market conditions.

Noxopharm Limited reported a 36.5% increase in its annual loss to $4.88 million as it progressed preparations for its SOF-SKN™ clinical trial and secured $2.6 million through convertible notes. The biotech continues to invest heavily in its inflammation and oncology drug pipeline while managing liquidity and strategic partnerships.

Wellard Limited reported a net profit of US$1.3 million for FY2025, driven by operational improvements and strategic asset sales. With the sale of its last livestock vessels completed, the company plans to delist from the ASX and return surplus cash to shareholders.

Echelon Resources reports a robust 34% revenue increase and 26% production growth for FY2025, driven by expanded stakes and drilling success at the Mereenie field. The company balances strong cash flow with strategic reinvestment and a modest dividend.

Echelon Resources Limited reported a robust financial year ending June 2025, driven by strategic asset acquisitions and strong commodity prices, delivering a 34% revenue increase and a near 20-fold jump in net profit after tax.

Experience Co Limited reported a solid FY25 financial performance with revenue rising 6% to $134.3 million and underlying EBITDA jumping 34%, driven by strong recovery in skydiving and adventure segments. The company declared a fully franked dividend and outlined an optimistic FY26 outlook focused on growth and efficiency.

Cynata Therapeutics reported a $9.39 million net loss for FY2025, slightly improved from the prior year, while progressing multiple clinical trials with key results expected in 2026. The company maintains a solid cash position and funding runway through mid-2026, supported by recent capital raises and an equity subscription agreement.

NTAW Holdings delivered a marked financial turnaround in the second half of FY2025, driven by operational restructuring and cost discipline. The company now sets its sights on consolidating growth and strengthening supplier partnerships in FY2026.

Foresta Group Holdings reported a $3.375 million net loss for FY2025 while making significant progress on its Kawerau biomass facility in New Zealand, securing key approvals, partnerships, and funding. The company aims to commence construction in FY2026, positioning itself in the renewable energy sector.

NEXTDC has delivered record FY25 financial results, surpassing revenue and EBITDA guidance while aggressively expanding its data centre footprint across Australia and Asia-Pacific. The company’s strengthened liquidity and strategic investments position it to capitalise on soaring AI and cloud demand.